Jeffrey Cummings, MD, ScD(HC)

Jeffrey Cummings, MD, ScD_(HC), is the Joy Chambers-Grundy Professor of Brain Science, Director of the Chambers-Gundy Center for Transformative Neuroscience, and Co-Director of the Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV).  Dr. Cummings is a Neurologist and is globally recognized for his contributions to Alzheimer’s research, drug development, and clinical trials.  He leads the UNLV Clinical Trials Observatory that studies all drugs in current clinical trials for Alzheimer’s disease to better inform drug development decisions.  Dr. Cummings has been honored with through the Henderson Award of the American Geriatrics Society, Distinguished Scientist Award of the American Association of Geriatric Psychiatry, Leadership and Achievement Award by the International Society of CNS Drug Development, the Bengt Winblad Lifetime Achievement Award from the national Alzheimer’s Association. International Psychogeriatric Association Distinguished Service Award, and the Alzheimer’s Drug Discovery Foundation’s Melvin R. Goodes Prize for Excellence in Drug Development.  Dr. Cummings is a Fellow to the American Academy for the Advancement of Science.  Dr. Cummings was the founding director of the Mary S. Easton Center for Alzheimer’s Disease Research at UCLA and founding director of the Cleveland Clinic Lou Ruvo Center for Brain Health. He is completed training in Neurology (Boston University) and Behavioral Neurology (Boston University) with additional training in Neuropsychiatry and Neuropathology (National Hospital for Nervous Diseases, Queen Square, London).  Dr. Cummings has published 43 books and over 900 peer-reviewed papers on Alzheimer’s disease, neuropsychiatry, and clinical trials.